Dr. Manouchehr Hessabi
← All writing
7 min readenvironment · pediatric · methods

Lead exposure in children: the sources, and what the evidence shows

How researchers measure childhood lead exposure, where children encounter it, and what the evidence does and does not establish about effects on development.

By Manouchehr Hessabi, MD, MPH

Lead is one of the oldest known poisons and one of the most carefully studied environmental exposures in children. That makes it a useful case for a question epidemiologists ask about every contaminant: how do we know a child has been exposed, how much exposure matters, and how do we separate the metal's effect from everything else in a child's life. Lead is also a reminder that "regulated" is not the same as "gone."

This is an explainer, not medical guidance. The goal is to show how the science is built and what it supports, in the same careful spirit as the work on autism and the environment, where measuring an exposure well is half the battle.

What "lead exposure" means and how it is measured

In children, lead exposure is usually measured as a blood lead level, reported in micrograms per deciliter, abbreviated µg/dL. A blood lead level is a biomarker, a measurable signal in the body that stands in for an exposure we cannot observe directly. It reflects recent and ongoing exposure rather than a lifetime total, because lead moves out of blood and into bone over months.

The U.S. Centers for Disease Control and Prevention (CDC) uses a blood lead reference value to flag children who have more lead in their blood than most. In October 2021, the CDC lowered that reference value from 5.0 µg/dL to 3.5 µg/dL, the change is described in the agency's own update on the blood lead reference value.

One point is easy to misread, so it is worth stating plainly. The reference value is a statistical benchmark, the 97.5th percentile of blood lead levels among U.S. children ages one to five, drawn from national survey data. It is not a threshold below which lead is safe. It is the line that identifies the roughly 2.5 percent of children with the highest measured levels, so that families and clinicians can act earlier. Confusing a percentile with a safety cutoff is a classic way to misread a public-health number.

Why scientists say there is no safe level

The World Health Organization (WHO) states that there is no level of lead exposure known to be without harmful effects. In its lead poisoning fact sheet, the WHO notes that even blood lead concentrations as low as 3.5 µg/dL may be associated with reduced intelligence, behavioral difficulties, and learning problems in children, and that the developing nervous system is especially vulnerable.

The careful word there is "associated with." Across many studies, higher early childhood lead exposure tracks with lower later cognitive scores, and the relationship appears strongest at the lowest end of the exposure range, where each additional increment seems to matter most. Researchers describe this as a dose-response relationship without a clear safe floor. That pattern, repeated across populations and decades, is why agencies treat the health-based goal as zero exposure even when the regulatory action levels are higher.

Where children actually encounter lead

If lead in household paint was banned, why is childhood lead exposure still a live issue? Because the ban stopped new use, not the old paint already on the walls.

  • Paint and house dust. Lead-based paint was banned for residential use in the United States in 1978, but according to the U.S. Environmental Protection Agency (EPA), roughly three-quarters of homes built before 1978 still contain some lead-based paint. As that paint ages on windowsills, doors, and porches, it sheds chips and fine dust. The EPA's guidance on protecting families from sources of lead describes how young children take it in through ordinary hand-to-mouth behavior. Deteriorating paint and the dust it creates remain the most common source for U.S. children.
  • Drinking water. Lead can dissolve into tap water from lead service lines and older plumbing. The EPA finalized its Lead and Copper Rule Improvements in October 2024, lowering the action level for lead in drinking water from 15 to 10 parts per billion and requiring most water systems to replace lead service lines within ten years.
  • Soil, imported goods, and occupational carry-home. Lead persists in soil near old painted structures and busy roadways from the leaded-gasoline era. It also turns up in some imported pottery, spices, cosmetics, and traditional remedies, and it can ride home on the clothing of adults who work with the metal.

A useful framing here is that the action level for water is a treatment trigger, not a verdict that lower numbers are harmless. The EPA's health-based goal for lead in drinking water is zero, consistent with the "no safe level" position. An action level tells a utility when it must act, it does not redefine safety.

What the evidence does and does not establish

The strongest and most consistent finding is that early childhood lead exposure is associated with measurable effects on the developing brain: lower IQ, shorter attention span, and more behavioral and learning difficulties, as summarized by both the CDC and WHO. These effects can be lasting, and there is no treatment that reverses the neurodevelopmental impact, which is why the entire field emphasizes prevention over remediation after the fact.

What the evidence does not support is precise, deterministic prediction for an individual child. Epidemiology describes risk across populations. A given child's trajectory depends on many factors, and a single blood lead level is a snapshot, not a forecast. Honest science states the association and its strength, and resists turning a population-level signal into an individual prophecy.

Separating lead's effect from everything around it

This is where study design earns its keep, and where readers should be most skeptical of tidy headlines. Childhood lead exposure is not randomly distributed. It is more common in older, lower-income housing, which also tends to coincide with other stressors that independently affect child development, things like nutrition, environmental noise, and educational resources.

A variable like this, tied to both the exposure and the outcome, is a confounder, and it can make an exposure look more or less harmful than it truly is. Strong studies handle confounding deliberately: by measuring and adjusting for socioeconomic factors, by comparing siblings, or by exploiting natural changes such as the removal of lead from gasoline. The reason the lead-and- development conclusion is trusted is not one dramatic study. It is that the association survives this scrutiny across many populations, designs, and decades. Replication under different conditions, not a single striking result, is what builds scientific confidence.

What has changed, and what it signals

Two recent shifts point the same direction. The CDC lowered its blood lead reference value in 2021, widening the group of children flagged for early follow-up, and the EPA tightened its drinking-water rule in 2024, lowering the action level and mandating removal of lead pipes. Neither change reflects a sudden discovery. Both reflect the slow accumulation of evidence that effects appear at lower exposures than once assumed, and the policy judgment that the right response is to keep lowering the bar.

For anyone reading environmental-health research, lead is a clean teaching case. It shows how a biomarker stands in for an exposure, why a statistical reference value is not a safety line, how a regulated hazard can persist in the built environment, and why confounding makes causal claims hard to earn. Those same habits of thought carry over to far messier exposures where the evidence is younger and the stakes are just as high.

Readers who want to see how these methods are applied to environmental exposures and child neurodevelopment can explore the peer-reviewed publications behind this work.

About the author. Dr. Manouchehr Hessabi is a physician-epidemiologist and Senior Research Scientist at the BERD core of UTHealth Houston's Center for Clinical and Translational Sciences. See his peer-reviewed publications or research programs.